Skip to main content
SpringerLink
Log in

The EMEA has recommended the suspension of marketing authorisations for all carisoprodol-containing products

  • Media release
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

REFERENCE

  1. EMEA.European Medicines Agency recommends suspension of marketing authorisations for carisoprodol-containing medicinal products. Media Release: 16 Nov 2007. Available from: URL: http://www.emea.europe.eu

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

The EMEA has recommended the suspension of marketing authorisations for all carisoprodol-containing products. React. Wkly. 1179, 5 (2007). https://doi.org/10.2165/00128415-200711790-00011

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00128415-200711790-00011

Keywords

Search

Navigation